Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NKX3-2
|
ENSG00000109705.7 | NK3 homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NKX3-2 | hg19_v2_chr4_-_13546632_13546674 | -0.02 | 8.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_99573677 | 3.97 |
ENST00000292401.4
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
chr15_+_89402148 | 3.82 |
ENST00000560601.1
|
ACAN
|
aggrecan |
chr11_-_102401469 | 3.77 |
ENST00000260227.4
|
MMP7
|
matrix metallopeptidase 7 (matrilysin, uterine) |
chr17_+_68071389 | 3.40 |
ENST00000283936.1
ENST00000392671.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr11_-_26593649 | 3.31 |
ENST00000455601.2
|
MUC15
|
mucin 15, cell surface associated |
chr7_-_120498357 | 3.17 |
ENST00000415871.1
ENST00000222747.3 ENST00000430985.1 |
TSPAN12
|
tetraspanin 12 |
chr5_+_78407602 | 3.13 |
ENST00000274353.5
ENST00000524080.1 |
BHMT
|
betaine--homocysteine S-methyltransferase |
chrX_+_105937068 | 2.99 |
ENST00000324342.3
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
chr3_+_125694347 | 2.98 |
ENST00000505382.1
ENST00000511082.1 |
ROPN1B
|
rhophilin associated tail protein 1B |
chrX_+_105936982 | 2.66 |
ENST00000418562.1
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
chr11_-_128737163 | 2.54 |
ENST00000324003.3
ENST00000392665.2 |
KCNJ1
|
potassium inwardly-rectifying channel, subfamily J, member 1 |
chr12_-_54978086 | 2.53 |
ENST00000553113.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
chr11_-_128737259 | 2.52 |
ENST00000440599.2
ENST00000392666.1 ENST00000324036.3 |
KCNJ1
|
potassium inwardly-rectifying channel, subfamily J, member 1 |
chr12_+_56075330 | 2.40 |
ENST00000394252.3
|
METTL7B
|
methyltransferase like 7B |
chr11_-_119993979 | 2.31 |
ENST00000524816.3
ENST00000525327.1 |
TRIM29
|
tripartite motif containing 29 |
chr8_+_35649365 | 2.31 |
ENST00000437887.1
|
AC012215.1
|
Uncharacterized protein |
chr6_-_47010061 | 2.24 |
ENST00000371253.2
|
GPR110
|
G protein-coupled receptor 110 |
chr5_+_169780485 | 2.22 |
ENST00000377360.4
|
KCNIP1
|
Kv channel interacting protein 1 |
chr11_-_26593779 | 2.18 |
ENST00000529533.1
|
MUC15
|
mucin 15, cell surface associated |
chr7_-_50628745 | 2.16 |
ENST00000380984.4
ENST00000357936.5 ENST00000426377.1 |
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
chr11_+_34642656 | 2.15 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
chr2_+_79347577 | 2.14 |
ENST00000233735.1
|
REG1A
|
regenerating islet-derived 1 alpha |
chr10_+_5005445 | 2.03 |
ENST00000380872.4
|
AKR1C1
|
aldo-keto reductase family 1, member C1 |
chr11_-_26593677 | 2.01 |
ENST00000527569.1
|
MUC15
|
mucin 15, cell surface associated |
chr7_-_99573640 | 2.01 |
ENST00000411734.1
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
chr2_-_220435963 | 1.93 |
ENST00000373876.1
ENST00000404537.1 ENST00000603926.1 ENST00000373873.4 ENST00000289656.3 |
OBSL1
|
obscurin-like 1 |
chr17_+_68071458 | 1.90 |
ENST00000589377.1
|
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chrX_-_49965663 | 1.83 |
ENST00000376056.2
ENST00000376058.2 ENST00000358526.2 |
AKAP4
|
A kinase (PRKA) anchor protein 4 |
chr5_+_169931009 | 1.80 |
ENST00000328939.4
ENST00000390656.4 |
KCNIP1
|
Kv channel interacting protein 1 |
chr5_+_68711209 | 1.80 |
ENST00000512803.1
|
MARVELD2
|
MARVEL domain containing 2 |
chr12_-_53298841 | 1.78 |
ENST00000293308.6
|
KRT8
|
keratin 8 |
chr10_-_98031310 | 1.67 |
ENST00000427367.2
ENST00000413476.2 |
BLNK
|
B-cell linker |
chr6_-_160679905 | 1.58 |
ENST00000366953.3
|
SLC22A2
|
solute carrier family 22 (organic cation transporter), member 2 |
chr16_-_20566616 | 1.58 |
ENST00000569163.1
|
ACSM2B
|
acyl-CoA synthetase medium-chain family member 2B |
chr14_-_67859422 | 1.58 |
ENST00000556532.1
|
PLEK2
|
pleckstrin 2 |
chr1_-_204183071 | 1.56 |
ENST00000308302.3
|
GOLT1A
|
golgi transport 1A |
chr4_-_168155700 | 1.56 |
ENST00000357545.4
ENST00000512648.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chrX_-_107681633 | 1.54 |
ENST00000394872.2
ENST00000334504.7 |
COL4A6
|
collagen, type IV, alpha 6 |
chrX_+_38420623 | 1.54 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
chr9_-_34397800 | 1.49 |
ENST00000297623.2
|
C9orf24
|
chromosome 9 open reading frame 24 |
chr9_+_35906176 | 1.49 |
ENST00000354323.2
|
HRCT1
|
histidine rich carboxyl terminus 1 |
chr2_+_17721920 | 1.49 |
ENST00000295156.4
|
VSNL1
|
visinin-like 1 |
chr3_-_116163830 | 1.48 |
ENST00000333617.4
|
LSAMP
|
limbic system-associated membrane protein |
chr10_-_98031265 | 1.47 |
ENST00000224337.5
ENST00000371176.2 |
BLNK
|
B-cell linker |
chr12_-_122296755 | 1.46 |
ENST00000289004.4
|
HPD
|
4-hydroxyphenylpyruvate dioxygenase |
chr16_-_21289627 | 1.46 |
ENST00000396023.2
ENST00000415987.2 |
CRYM
|
crystallin, mu |
chr10_-_95360983 | 1.45 |
ENST00000371464.3
|
RBP4
|
retinol binding protein 4, plasma |
chr9_+_34458771 | 1.45 |
ENST00000437363.1
ENST00000242317.4 |
DNAI1
|
dynein, axonemal, intermediate chain 1 |
chr7_-_107642348 | 1.44 |
ENST00000393561.1
|
LAMB1
|
laminin, beta 1 |
chr5_+_40909354 | 1.44 |
ENST00000313164.9
|
C7
|
complement component 7 |
chr2_+_155555201 | 1.44 |
ENST00000544049.1
|
KCNJ3
|
potassium inwardly-rectifying channel, subfamily J, member 3 |
chr2_-_220436248 | 1.43 |
ENST00000265318.4
|
OBSL1
|
obscurin-like 1 |
chr4_-_168155730 | 1.43 |
ENST00000502330.1
ENST00000357154.3 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr19_-_51412584 | 1.42 |
ENST00000431178.2
|
KLK4
|
kallikrein-related peptidase 4 |
chrX_-_107681555 | 1.39 |
ENST00000545689.1
ENST00000538570.1 |
COL4A6
|
collagen, type IV, alpha 6 |
chr5_-_35048047 | 1.37 |
ENST00000231420.6
|
AGXT2
|
alanine--glyoxylate aminotransferase 2 |
chr17_-_55911970 | 1.34 |
ENST00000581805.1
ENST00000580960.1 |
RP11-60A24.3
|
RP11-60A24.3 |
chr3_-_149688502 | 1.34 |
ENST00000481767.1
ENST00000475518.1 |
PFN2
|
profilin 2 |
chrX_+_38420783 | 1.34 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
chr5_+_169931249 | 1.33 |
ENST00000520740.1
|
KCNIP1
|
Kv channel interacting protein 1 |
chr8_+_87111059 | 1.32 |
ENST00000285393.3
|
ATP6V0D2
|
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 |
chr1_+_176432298 | 1.32 |
ENST00000367661.3
ENST00000367662.3 |
PAPPA2
|
pappalysin 2 |
chr1_-_217262933 | 1.32 |
ENST00000359162.2
|
ESRRG
|
estrogen-related receptor gamma |
chr4_-_168155577 | 1.29 |
ENST00000541354.1
ENST00000509854.1 ENST00000512681.1 ENST00000421836.2 ENST00000510741.1 ENST00000510403.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr19_-_36297348 | 1.29 |
ENST00000589835.1
|
PRODH2
|
proline dehydrogenase (oxidase) 2 |
chr1_-_160040038 | 1.27 |
ENST00000368089.3
|
KCNJ10
|
potassium inwardly-rectifying channel, subfamily J, member 10 |
chr12_-_21927736 | 1.27 |
ENST00000240662.2
|
KCNJ8
|
potassium inwardly-rectifying channel, subfamily J, member 8 |
chr4_-_168155417 | 1.27 |
ENST00000511269.1
ENST00000506697.1 ENST00000512042.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr11_-_8739383 | 1.26 |
ENST00000531060.1
|
ST5
|
suppression of tumorigenicity 5 |
chrX_+_18725758 | 1.26 |
ENST00000472826.1
ENST00000544635.1 ENST00000496075.2 |
PPEF1
|
protein phosphatase, EF-hand calcium binding domain 1 |
chr15_-_56035177 | 1.25 |
ENST00000389286.4
ENST00000561292.1 |
PRTG
|
protogenin |
chr1_-_217262969 | 1.24 |
ENST00000361525.3
|
ESRRG
|
estrogen-related receptor gamma |
chr1_-_24438664 | 1.21 |
ENST00000374434.3
ENST00000330966.7 ENST00000329601.7 |
MYOM3
|
myomesin 3 |
chr1_-_95783809 | 1.21 |
ENST00000423410.1
|
RP4-586O15.1
|
RP4-586O15.1 |
chr8_+_144295067 | 1.20 |
ENST00000330824.2
|
GPIHBP1
|
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 |
chr11_-_8739566 | 1.19 |
ENST00000533020.1
|
ST5
|
suppression of tumorigenicity 5 |
chr6_+_43112037 | 1.19 |
ENST00000473339.1
|
PTK7
|
protein tyrosine kinase 7 |
chr15_+_69857515 | 1.19 |
ENST00000559477.1
|
RP11-279F6.1
|
RP11-279F6.1 |
chrX_-_15683147 | 1.17 |
ENST00000380342.3
|
TMEM27
|
transmembrane protein 27 |
chr1_-_216978709 | 1.17 |
ENST00000360012.3
|
ESRRG
|
estrogen-related receptor gamma |
chr4_-_175041663 | 1.17 |
ENST00000503140.1
|
RP11-148L24.1
|
RP11-148L24.1 |
chr20_-_39995467 | 1.16 |
ENST00000332312.3
|
EMILIN3
|
elastin microfibril interfacer 3 |
chr1_-_21059029 | 1.15 |
ENST00000444387.2
ENST00000375031.1 ENST00000518294.1 |
SH2D5
|
SH2 domain containing 5 |
chr1_-_217250231 | 1.15 |
ENST00000493748.1
ENST00000463665.1 |
ESRRG
|
estrogen-related receptor gamma |
chr19_+_48867652 | 1.13 |
ENST00000344846.2
|
SYNGR4
|
synaptogyrin 4 |
chr6_+_24357131 | 1.13 |
ENST00000274766.1
|
KAAG1
|
kidney associated antigen 1 |
chr8_+_86376081 | 1.12 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
chr1_-_24469602 | 1.10 |
ENST00000270800.1
|
IL22RA1
|
interleukin 22 receptor, alpha 1 |
chr11_-_1036706 | 1.09 |
ENST00000421673.2
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming |
chr3_+_50192537 | 1.09 |
ENST00000002829.3
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr3_-_100551141 | 1.08 |
ENST00000478235.1
ENST00000471901.1 |
ABI3BP
|
ABI family, member 3 (NESH) binding protein |
chr15_-_80695917 | 1.06 |
ENST00000559008.1
|
RP11-210M15.2
|
Uncharacterized protein |
chr18_+_28898052 | 1.06 |
ENST00000257192.4
|
DSG1
|
desmoglein 1 |
chr3_-_42917363 | 1.06 |
ENST00000437102.1
|
CYP8B1
|
cytochrome P450, family 8, subfamily B, polypeptide 1 |
chr15_+_97326619 | 1.05 |
ENST00000328504.3
|
SPATA8
|
spermatogenesis associated 8 |
chr12_+_56473939 | 1.05 |
ENST00000450146.2
|
ERBB3
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
chr9_+_35161998 | 1.05 |
ENST00000396787.1
ENST00000378495.3 ENST00000378496.4 |
UNC13B
|
unc-13 homolog B (C. elegans) |
chr6_-_136788001 | 1.04 |
ENST00000544465.1
|
MAP7
|
microtubule-associated protein 7 |
chr1_+_10509971 | 1.04 |
ENST00000320498.4
|
CORT
|
cortistatin |
chr3_+_50192499 | 1.02 |
ENST00000413852.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr12_+_6309517 | 1.02 |
ENST00000382519.4
ENST00000009180.4 |
CD9
|
CD9 molecule |
chr7_-_8276508 | 1.01 |
ENST00000401396.1
ENST00000317367.5 |
ICA1
|
islet cell autoantigen 1, 69kDa |
chr9_+_34458851 | 1.01 |
ENST00000545019.1
|
DNAI1
|
dynein, axonemal, intermediate chain 1 |
chr1_+_210111534 | 0.99 |
ENST00000422431.1
ENST00000534859.1 ENST00000399639.2 ENST00000537238.1 |
SYT14
|
synaptotagmin XIV |
chr10_+_7745232 | 0.99 |
ENST00000358415.4
|
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
chr7_-_117512264 | 0.99 |
ENST00000454375.1
|
CTTNBP2
|
cortactin binding protein 2 |
chr3_-_139199565 | 0.99 |
ENST00000511956.1
|
RBP2
|
retinol binding protein 2, cellular |
chr2_-_42160486 | 0.98 |
ENST00000427054.1
|
AC104654.2
|
AC104654.2 |
chr4_+_148402069 | 0.98 |
ENST00000358556.4
ENST00000339690.5 ENST00000511804.1 ENST00000324300.5 |
EDNRA
|
endothelin receptor type A |
chr18_+_55816546 | 0.97 |
ENST00000435432.2
ENST00000357895.5 ENST00000586263.1 |
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr2_-_160919112 | 0.96 |
ENST00000283243.7
ENST00000392771.1 |
PLA2R1
|
phospholipase A2 receptor 1, 180kDa |
chr3_+_50192457 | 0.96 |
ENST00000414301.1
ENST00000450338.1 |
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr1_+_60280458 | 0.95 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
chr10_+_7745303 | 0.95 |
ENST00000429820.1
ENST00000379587.4 |
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
chr1_+_6845578 | 0.94 |
ENST00000467404.2
ENST00000439411.2 |
CAMTA1
|
calmodulin binding transcription activator 1 |
chr11_-_111175739 | 0.93 |
ENST00000532918.1
|
COLCA1
|
colorectal cancer associated 1 |
chrX_-_71526813 | 0.92 |
ENST00000246139.5
|
CITED1
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 |
chr7_-_79082867 | 0.90 |
ENST00000419488.1
ENST00000354212.4 |
MAGI2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
chr11_-_74408739 | 0.90 |
ENST00000529912.1
|
CHRDL2
|
chordin-like 2 |
chr13_+_37247934 | 0.89 |
ENST00000315190.3
|
SERTM1
|
serine-rich and transmembrane domain containing 1 |
chr4_-_141348763 | 0.89 |
ENST00000509477.1
|
CLGN
|
calmegin |
chr6_-_27279949 | 0.88 |
ENST00000444565.1
ENST00000377451.2 |
POM121L2
|
POM121 transmembrane nucleoporin-like 2 |
chrX_+_76709648 | 0.87 |
ENST00000439435.1
|
FGF16
|
fibroblast growth factor 16 |
chr3_-_160117035 | 0.87 |
ENST00000489004.1
ENST00000496589.1 |
IFT80
|
intraflagellar transport 80 homolog (Chlamydomonas) |
chr16_+_57406368 | 0.87 |
ENST00000006053.6
ENST00000563383.1 |
CX3CL1
|
chemokine (C-X3-C motif) ligand 1 |
chr16_-_20416053 | 0.86 |
ENST00000302451.4
|
PDILT
|
protein disulfide isomerase-like, testis expressed |
chr17_+_30593195 | 0.86 |
ENST00000431505.2
ENST00000269051.4 ENST00000538145.1 |
RHBDL3
|
rhomboid, veinlet-like 3 (Drosophila) |
chr14_+_21467414 | 0.84 |
ENST00000554422.1
ENST00000298681.4 |
SLC39A2
|
solute carrier family 39 (zinc transporter), member 2 |
chr8_-_30706608 | 0.84 |
ENST00000256246.2
|
TEX15
|
testis expressed 15 |
chr7_-_1595756 | 0.83 |
ENST00000441933.1
|
TMEM184A
|
transmembrane protein 184A |
chr12_+_70219052 | 0.83 |
ENST00000552032.2
ENST00000547771.2 |
MYRFL
|
myelin regulatory factor-like |
chr5_+_68710906 | 0.82 |
ENST00000325631.5
ENST00000454295.2 |
MARVELD2
|
MARVEL domain containing 2 |
chr12_-_10978957 | 0.82 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
chr3_-_160117301 | 0.81 |
ENST00000326448.7
ENST00000498409.1 ENST00000475677.1 ENST00000478536.1 |
IFT80
|
intraflagellar transport 80 homolog (Chlamydomonas) |
chr9_+_124329336 | 0.80 |
ENST00000394340.3
ENST00000436835.1 ENST00000259371.2 |
DAB2IP
|
DAB2 interacting protein |
chr10_-_7708918 | 0.80 |
ENST00000256861.6
ENST00000397146.2 ENST00000446830.2 ENST00000397145.2 |
ITIH5
|
inter-alpha-trypsin inhibitor heavy chain family, member 5 |
chr6_-_11382478 | 0.80 |
ENST00000397378.3
ENST00000513989.1 ENST00000508546.1 ENST00000504387.1 |
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9 |
chr7_-_135412925 | 0.79 |
ENST00000354042.4
|
SLC13A4
|
solute carrier family 13 (sodium/sulfate symporter), member 4 |
chr4_+_123300591 | 0.79 |
ENST00000439307.1
ENST00000388724.2 |
ADAD1
|
adenosine deaminase domain containing 1 (testis-specific) |
chr6_-_138833630 | 0.79 |
ENST00000533765.1
|
NHSL1
|
NHS-like 1 |
chr17_-_39928106 | 0.79 |
ENST00000540235.1
|
JUP
|
junction plakoglobin |
chr2_+_186603545 | 0.79 |
ENST00000424728.1
|
FSIP2
|
fibrous sheath interacting protein 2 |
chr4_+_113970772 | 0.78 |
ENST00000504454.1
ENST00000394537.3 ENST00000357077.4 ENST00000264366.6 |
ANK2
|
ankyrin 2, neuronal |
chr19_+_36545833 | 0.77 |
ENST00000401500.2
ENST00000270301.7 ENST00000427823.2 |
WDR62
|
WD repeat domain 62 |
chr2_-_180610767 | 0.77 |
ENST00000409343.1
|
ZNF385B
|
zinc finger protein 385B |
chr3_+_132316081 | 0.77 |
ENST00000249887.2
|
ACKR4
|
atypical chemokine receptor 4 |
chr4_+_159727222 | 0.77 |
ENST00000512986.1
|
FNIP2
|
folliculin interacting protein 2 |
chr9_+_15553055 | 0.77 |
ENST00000380701.3
|
CCDC171
|
coiled-coil domain containing 171 |
chr1_+_205473784 | 0.76 |
ENST00000478560.1
ENST00000443813.2 |
CDK18
|
cyclin-dependent kinase 18 |
chr10_+_18629628 | 0.76 |
ENST00000377329.4
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
chr12_+_22852791 | 0.75 |
ENST00000413794.2
|
RP11-114G22.1
|
RP11-114G22.1 |
chr4_+_169575875 | 0.75 |
ENST00000503457.1
|
PALLD
|
palladin, cytoskeletal associated protein |
chr19_-_38747172 | 0.74 |
ENST00000347262.4
ENST00000591585.1 ENST00000301242.4 |
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
chr17_+_4854375 | 0.74 |
ENST00000521811.1
ENST00000519602.1 ENST00000323997.6 ENST00000522249.1 ENST00000519584.1 |
ENO3
|
enolase 3 (beta, muscle) |
chr3_-_149688896 | 0.74 |
ENST00000239940.7
|
PFN2
|
profilin 2 |
chr1_+_6845497 | 0.73 |
ENST00000473578.1
ENST00000557126.1 |
CAMTA1
|
calmodulin binding transcription activator 1 |
chr5_+_127039075 | 0.72 |
ENST00000514853.2
|
CTC-228N24.1
|
CTC-228N24.1 |
chr1_+_210111570 | 0.72 |
ENST00000367019.1
ENST00000472886.1 |
SYT14
|
synaptotagmin XIV |
chr10_+_47746929 | 0.71 |
ENST00000340243.6
ENST00000374277.5 ENST00000449464.2 ENST00000538825.1 ENST00000335083.5 |
ANXA8L2
AL603965.1
|
annexin A8-like 2 Protein LOC100996760 |
chr17_-_74137374 | 0.71 |
ENST00000322957.6
|
FOXJ1
|
forkhead box J1 |
chr4_-_48018680 | 0.71 |
ENST00000513178.1
|
CNGA1
|
cyclic nucleotide gated channel alpha 1 |
chr11_-_119993734 | 0.71 |
ENST00000533302.1
|
TRIM29
|
tripartite motif containing 29 |
chr9_-_23821842 | 0.71 |
ENST00000544538.1
|
ELAVL2
|
ELAV like neuron-specific RNA binding protein 2 |
chr11_-_123065989 | 0.71 |
ENST00000448775.2
|
CLMP
|
CXADR-like membrane protein |
chr1_+_20617362 | 0.70 |
ENST00000375079.2
ENST00000289815.8 ENST00000375083.4 ENST00000289825.4 |
VWA5B1
|
von Willebrand factor A domain containing 5B1 |
chr9_+_6328360 | 0.70 |
ENST00000381428.1
ENST00000314556.3 |
TPD52L3
|
tumor protein D52-like 3 |
chr15_-_37393406 | 0.70 |
ENST00000338564.5
ENST00000558313.1 ENST00000340545.5 |
MEIS2
|
Meis homeobox 2 |
chr1_+_86889769 | 0.70 |
ENST00000370565.4
|
CLCA2
|
chloride channel accessory 2 |
chr2_+_98703595 | 0.69 |
ENST00000435344.1
|
VWA3B
|
von Willebrand factor A domain containing 3B |
chr12_-_80084862 | 0.69 |
ENST00000328827.4
|
PAWR
|
PRKC, apoptosis, WT1, regulator |
chr20_+_42984330 | 0.69 |
ENST00000316673.4
ENST00000609795.1 ENST00000457232.1 ENST00000609262.1 |
HNF4A
|
hepatocyte nuclear factor 4, alpha |
chr6_-_47009996 | 0.69 |
ENST00000371243.2
|
GPR110
|
G protein-coupled receptor 110 |
chr12_+_6309963 | 0.68 |
ENST00000382515.2
|
CD9
|
CD9 molecule |
chr17_-_73511584 | 0.67 |
ENST00000321617.3
|
CASKIN2
|
CASK interacting protein 2 |
chr9_+_15552867 | 0.67 |
ENST00000535968.1
|
CCDC171
|
coiled-coil domain containing 171 |
chr8_-_19093121 | 0.66 |
ENST00000518417.1
|
RP11-1080G15.1
|
RP11-1080G15.1 |
chr2_+_98703643 | 0.66 |
ENST00000477737.1
|
VWA3B
|
von Willebrand factor A domain containing 3B |
chr3_-_100558953 | 0.66 |
ENST00000533795.1
|
ABI3BP
|
ABI family, member 3 (NESH) binding protein |
chr10_-_47173994 | 0.66 |
ENST00000414655.2
ENST00000545298.1 ENST00000359178.4 ENST00000358140.4 ENST00000503031.1 |
ANXA8L1
LINC00842
|
annexin A8-like 1 long intergenic non-protein coding RNA 842 |
chr4_-_141348999 | 0.65 |
ENST00000325617.5
|
CLGN
|
calmegin |
chr15_+_97326659 | 0.65 |
ENST00000558553.1
|
SPATA8
|
spermatogenesis associated 8 |
chr16_-_86542652 | 0.65 |
ENST00000599749.1
|
FENDRR
|
FOXF1 adjacent non-coding developmental regulatory RNA |
chr2_+_171673417 | 0.65 |
ENST00000344257.5
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa) |
chr8_-_123706338 | 0.65 |
ENST00000521608.1
|
RP11-973F15.1
|
long intergenic non-protein coding RNA 1151 |
chr19_-_6720686 | 0.65 |
ENST00000245907.6
|
C3
|
complement component 3 |
chr11_-_107590383 | 0.64 |
ENST00000525934.1
ENST00000531293.1 |
SLN
|
sarcolipin |
chr4_-_141348789 | 0.63 |
ENST00000414773.1
|
CLGN
|
calmegin |
chr4_+_159727272 | 0.63 |
ENST00000379346.3
|
FNIP2
|
folliculin interacting protein 2 |
chr2_-_45165994 | 0.63 |
ENST00000444871.2
|
RP11-89K21.1
|
RP11-89K21.1 |
chr1_-_222886526 | 0.62 |
ENST00000541237.1
|
AIDA
|
axin interactor, dorsalization associated |
chr10_+_35415851 | 0.62 |
ENST00000374726.3
|
CREM
|
cAMP responsive element modulator |
chr8_-_49834299 | 0.62 |
ENST00000396822.1
|
SNAI2
|
snail family zinc finger 2 |
chr6_+_24775641 | 0.62 |
ENST00000378054.2
ENST00000476555.1 |
GMNN
|
geminin, DNA replication inhibitor |
chr15_+_41136734 | 0.62 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr19_+_41497178 | 0.61 |
ENST00000324071.4
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6 |
chr3_-_49933249 | 0.61 |
ENST00000434765.1
|
MST1R
|
macrophage stimulating 1 receptor (c-met-related tyrosine kinase) |
chr10_+_101088836 | 0.61 |
ENST00000356713.4
|
CNNM1
|
cyclin M1 |
chr6_+_155443048 | 0.60 |
ENST00000535583.1
|
TIAM2
|
T-cell lymphoma invasion and metastasis 2 |
chr6_-_30080863 | 0.59 |
ENST00000540829.1
|
TRIM31
|
tripartite motif containing 31 |
chrX_-_131262048 | 0.59 |
ENST00000298542.4
|
FRMD7
|
FERM domain containing 7 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.7 | 2.2 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
0.5 | 1.4 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.5 | 1.4 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
0.4 | 1.1 | GO:0042938 | dipeptide transport(GO:0042938) |
0.4 | 1.1 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.3 | 1.0 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.3 | 1.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.3 | 1.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.3 | 3.9 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.3 | 2.1 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.3 | 1.8 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.2 | 1.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.2 | 1.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.7 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.2 | 5.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 13.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 3.1 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.2 | 0.6 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.2 | 0.6 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.2 | 4.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 4.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 0.6 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.2 | 1.3 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.2 | 3.8 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.2 | 1.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.6 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.2 | 0.8 | GO:1900747 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.2 | 0.8 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.2 | 0.5 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.1 | 1.0 | GO:2000302 | regulation of synaptic vesicle priming(GO:0010807) presynaptic dense core granule exocytosis(GO:0099525) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.6 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 3.6 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.4 | GO:0044335 | neural crest cell fate commitment(GO:0014034) canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
0.1 | 6.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 1.0 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 2.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.9 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.1 | 0.9 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.6 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 0.7 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 0.9 | GO:0071105 | response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
0.1 | 1.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.8 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.7 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 1.6 | GO:1901374 | acetate ester transport(GO:1901374) |
0.1 | 0.4 | GO:0048691 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 0.3 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.1 | 1.8 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 1.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 2.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.8 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 7.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.5 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 0.6 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.1 | 0.8 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 1.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 1.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.5 | GO:0035900 | response to isolation stress(GO:0035900) |
0.1 | 0.6 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.1 | 1.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.3 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.1 | 3.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.3 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 8.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 1.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.4 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.1 | 1.2 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.1 | 1.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.3 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.1 | 0.4 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.1 | 0.5 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 1.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.4 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.1 | 0.4 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.1 | 0.6 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.3 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.0 | 0.1 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
0.0 | 0.3 | GO:1904721 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.0 | 1.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.6 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.5 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 5.3 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.0 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 2.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.0 | 0.5 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.1 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.0 | 0.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.3 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.0 | 0.6 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
0.0 | 0.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 1.4 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 2.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.2 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
0.0 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.2 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.6 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.0 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.2 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.0 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 3.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.6 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 1.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.2 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.4 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.2 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.0 | 0.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.4 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 1.5 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.8 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.0 | 2.2 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.0 | 0.9 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.0 | 1.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 1.0 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.0 | 1.7 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.7 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.3 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.0 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.3 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.8 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.8 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.8 | GO:0007099 | centriole replication(GO:0007099) |
0.0 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 1.9 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.5 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 1.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.2 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 1.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.6 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 2.1 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 1.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.4 | 3.4 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 1.0 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.3 | 2.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.3 | 0.8 | GO:1990032 | parallel fiber(GO:1990032) |
0.2 | 1.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 2.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.8 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
0.2 | 2.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 1.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.0 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.6 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.1 | 1.0 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 17.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 1.1 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 12.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.9 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 2.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 1.8 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 1.0 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.4 | GO:0030055 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) cell-substrate junction(GO:0030055) |
0.0 | 1.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.6 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 1.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.5 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 1.1 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 11.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 1.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 2.1 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.1 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.0 | 2.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.8 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 2.8 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.3 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.0 | 1.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 1.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 3.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 1.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 1.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.9 | 8.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.6 | 4.9 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.4 | 2.1 | GO:0047718 | androsterone dehydrogenase activity(GO:0047023) indanol dehydrogenase activity(GO:0047718) |
0.4 | 1.6 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
0.4 | 1.5 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.3 | 1.0 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.3 | 1.3 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.3 | 7.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.3 | 6.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 1.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.8 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.2 | 1.4 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.2 | 0.6 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.2 | 1.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 5.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 2.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 5.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.4 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.1 | 1.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 1.2 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 3.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.6 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.6 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.1 | 2.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.8 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 1.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 2.8 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 2.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 2.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.3 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.1 | 0.8 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 2.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 3.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 3.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.9 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.2 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.1 | 2.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 1.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 1.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.1 | 0.3 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.0 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 5.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 4.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 1.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.7 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 1.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 0.1 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.0 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 1.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 2.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 5.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 1.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.9 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 1.0 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) neurotrophin receptor activity(GO:0005030) |
0.0 | 1.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 2.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 2.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.6 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.0 | 0.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 1.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 1.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 3.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.4 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 2.5 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.2 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.7 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.8 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.0 | 1.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.1 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 0.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 1.4 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.5 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 1.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.7 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.0 | GO:0010858 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 3.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.0 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 9.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 6.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 2.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 6.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 3.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 7.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 2.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 1.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 5.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.7 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 14.9 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 8.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 3.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 4.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 3.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 2.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 3.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 5.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 2.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 3.2 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 1.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 1.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 1.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.5 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.6 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.8 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |